Complexity and diversity of hepatitis C virus RNA in African Americans and whites: Analysis of the envelope-coding domain

Journal of Infectious Diseases

Volumn 190, Issue 3, 2004, Pages 511-514

  Keenan, Erica D ^a   Rouster, Susan D ^a   Shire, Norah J ^a   Horn, Paul S ^b   Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AFRICAN AMERICAN; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CLONE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RACE DIFFERENCE; RNA ISOLATION; SEQUENCE ANALYSIS; SPECIES DIVERSITY; VIRUS ENVELOPE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AMINO ACID SEQUENCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

EID: 3242783315     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/421506     Document Type: Article

References (15)

1. Manns MP, McHutchinson JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358:958-65.
2. Reddy KR, Hoofnagle JH, Tong MJ, et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology 1999; 30:787-93.
3. McHutchison JG, Poynard T, Pianko S, et al. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. Gastroenterology 2000; 119:1317-23.
4. Polyak SJ, Faulkner G, Carithers RL Jr, Corey L, Gretch DR. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 1997; 175:1101-7.
5. Sherman KE, Rouster SD, Mendenhall C, Thee D. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Hepatology 1999; 30:265-70.
6. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 1994; 68:6672-83.
7. Grahovac B, Bingulac-Popovic J, Vucelic B, et al. Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C. J Clin Virol 2001; 20:85-9.
8. Grahovac B, Bingulac-Popovic J, Vucelic B, et al. Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy. Clin Chem Lab Med 2000; 38:905-10.
9. Hino K, Yamaguchi Y, Fujiwara D, et al. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study. J Viral Hepat 2000; 7:36-42.
10. Toyoda H, Fukuda Y, Koyama Y, Takamatsu J, Saito H, Hayakawa T. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 1997; 26:975-82.
11. Roque-Afonso AM, Robain M, Simoneau D, et al. Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus. J Infect Dis 2002; 185:728-33.
12. Sherman KE, Andreatta C, O'Brien J, Gutierrez A, Harris R. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 1996; 23:688-94.
13. Howell C, Jeffers L, Hoofnagle JH. Hepatitis C in African Americans: summary of a workshop. Gastroenterology 2000; 119:1385-96.
14. Sandres K, Dubois M, Pasquier C, et al. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy. J Virol 2000; 74:661-8.
15. Boulestin A, Sandres-Saune K, Payen JL, et al. Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha. J Med Virol 2002; 68:221-8.